• Adapted protein: With 44% branched chain amino acids to improve nutritional status and to counteract the metabolic disturbance related to hepatic encephalopathy^1-4
• Low in volume and sodium content according to recommendations⁵ for patients with ascites and oedema⁶
• With MCT (35% of fat) for easy absortion⁷
• With fibre to maintain gut physiology⁸

References:

1) Plauth M, Cabre E, Riggio O, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006;25(2):285-294.
2) Amodio P, Bemeur C, Butterworth R, et al. The Nutritional Management of Hepatic Encephalopathy in Patients With Cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology. 2013;58(1):325-336.
3) Gluud LL, Dam G, Les I, et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Library. 2007. CD001939
4) Kawaguchi T, Taniguchi E, Sata M. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis. Nutrition in Clinical Practice. 2013;28(5)580–588.
5) Ginés P, Angeli P, Lenz K, et al. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417.
6) Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087-2107.
7) Babayan VK. Medium chain triglycerides and structured lipids. Lipids. 1987;22(6):417-420.
8) Lochs H, Allison SP, Meier R, et al. Introductory to the ESPEN Guidelines on Enteral Nutrition: terminology, definitions and general topics. Clin Nutr. 2006;25(2):180-186.